1
/
of
1
Michael J. Madson
The Rise and Fall of Original OxyContin: A Rhetorical Study of Blame, Scapegoating, and Our Unrelieved Pain
The Rise and Fall of Original OxyContin: A Rhetorical Study of Blame, Scapegoating, and Our Unrelieved Pain
💎 Earn 361 Points (£3.61) on this item.
Regular price
£72.22 GBP
Regular price
Sale price
£72.22 GBP
Unit price
/
per
Taxes included.
Shipping calculated at checkout.
- Condition: Brand new
- UK Delivery times: Usually arrives within 2 - 3 working days
- UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Bulk ordering. Want 15 or more copies? Get a personalised quote and bigger discounts. Learn more about bulk orders.
Couldn't load pickup availability
- More about The Rise and Fall of Original OxyContin: A Rhetorical Study of Blame, Scapegoating, and Our Unrelieved Pain
The United States opioid crisis has wrought devastation on a massive scale. With closure elusive, much of the blame has fallen on a single pill, a long-acting oxycodone tablet called OxyContin. Perhaps one of the most notorious prescription painkillers on the market, OxyContin may be the best documented opioid in the country due to extensive litigation, regulation, and news coverage. Analyses of these documents can provide deeper insights into the drug's lifecycle as well as the shaping of public understandings of the crisis. Blame pervades our lived experiences, affecting how we norm and punish, explain and evade, reconcile and heal. This phenomenon has rarely been discussed by scholars, leaving gaps in our collective knowledge. Drawing on extensive documentation--from media coverage and court records to internal company emails--Madson examines who was blamed, how, and why. To do this, he has adapted for a new critical contextualized methodology to identify key players, map time-space axes, and pinpoint tipping points. Rather than pointing to a single cause, The Rise and Fall of Original OxyContin traces how blame shifted among drug makers, regulators, doctors, patients, and others over time, leaving some as scapegoats. Using clear, accessible language, it offers insight into how blame can influence public health, policy, and trust. The outcome is a preliminary model of blame discourse in pharmaceutical contexts, which aims to inform future research. Applications can be drawn to three critical areas of practice: pharmaceutical risk communication, organizational health literacy, and interprofessional education. The work provides valuable insights into the origins of miscommunication about risk, addiction, and corporate responsibility, and offers practical takeaways for future crisis communication and risk regulation.
- Publication date: 14 October 2026
- Page count: 240
- Dimensions: Height 241 mm; Width 165 mm; Thickness 21 mm
- Publisher: Oxford University Press Inc
- Format: Hardback
- ISBN-13: 9780197835265
This item can be found in:
UK and International shipping information
UK and International shipping information
UK Delivery and returns information:
- Delivery within 2 - 3 days when ordering in the UK.
- Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
- Returns policy: Return within 30 days of receipt for full refund.
International deliveries:
Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.
- Delivery times: within 5 - 10 days for international orders.
- Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
- Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
